Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?

Expert Opinion on Drug Metabolism & Toxicology
Gabriel StillemansLaure Elens

Abstract

Several antiretroviral drugs used to treat infection with the human immunodeficiency virus (HIV) are substrates of enzymes belonging to the cytochrome P450 (CYP) superfamily, which are polymorphically expressed. It may therefore be useful to take into account the genetic variation in these enzymes to predict the likelihood of anti-HIV treatment success, toxicity and the potential for drug-drug interactions. Areas covered: In this manuscript, the authors discuss the current state of knowledge regarding pharmacogenetic associations between CYP and all major antiretrovirals, as well as the importance of these associations. Expert opinion: While many pharmacogenetic associations for CYP have been described in the literature, replication studies are sometimes lacking. The implementation of this knowledge in clinical practice also remains difficult. Further efforts are required both to expand this field of knowledge and to enable its use in everyday clinical practice.

References

Mar 2, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carmina R FumazBonaventura Clotet
Jan 25, 2003·Clinical Pharmacology and Therapeutics·Chantal CsajkaThierry Buclin
Jun 10, 2003·Clinical Pharmacokinetics·Theodora E M S de Vries-SluijsMarchina E van der Ende
Oct 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Vishal LambaErin G Schuetz
Jan 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lucía GallegoVincent Soriano
Jul 13, 2004·Pharmacogenetics·Dyfrig A HughesMunir Pirmohamed
Feb 18, 2005·The Journal of Infectious Diseases·Ian SanneFranck Rousseau
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sonia Rodriguez-NovoaVincent Soriano
Aug 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W HaasUNKNOWN Adult AIDS Clinical Trials Group
Oct 7, 2006·The Lancet Infectious Diseases·Pam Das
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hiroyuki GatanagaShinichi Oka
Feb 19, 2008·The Journal of Antimicrobial Chemotherapy·Christoph WyenUNKNOWN German Competence Network for HIV/AIDS
Feb 22, 2008·Clinical Pharmacology and Therapeutics·R C E EstrelaG Suarez-Kurtz
Jan 10, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Marc VermeirAraz Raoof
Feb 20, 2009·Clinical Pharmacology and Therapeutics·M Arab-AlameddineUNKNOWN Swiss HIV Cohort Study
Nov 18, 2009·British Journal of Clinical Pharmacology·Jackson K MukonzoEleni Aklillu
Jul 20, 2010·The Journal of Antimicrobial Chemotherapy·Daniel F CarrClaudia P Cortes
Feb 4, 2011·The Journal of Infectious Diseases·Rubin LubomirovUNKNOWN Swiss HIV Cohort Study
Mar 29, 2011·The Journal of Antimicrobial Chemotherapy·Alessandro SchipaniUNKNOWN German Competence Network for HIV/AIDS
Apr 13, 2011·AIDS and Behavior·Christopher A Kenedi, Harold W Goforth
Sep 8, 2011·Antimicrobial Agents and Chemotherapy·Almudena SánchezUNKNOWN Tormes Group
Sep 9, 2011·European Journal of Clinical Pharmacology·Milimo MaimboYusuke Nakamura

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.